Intelligent Price To Sales Ratio from 2010 to 2025
| INBS Stock | USD 1.39 0.08 6.11% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 1.08 | Current Value 1.02 | Quarterly Volatility 2.5 K |
Check Intelligent Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intelligent Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 142.9 K or Selling General Administrative of 11.2 M, as well as many indicators such as Price To Sales Ratio of 1.02, Dividend Yield of 0.0 or PTB Ratio of 0.33. Intelligent financial statements analysis is a perfect complement when working with Intelligent Bio Valuation or Volatility modules.
Intelligent | Price To Sales Ratio |
Latest Intelligent Bio's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Intelligent Bio Solutions over the last few years. Price to Sales Ratio is figured by comparing Intelligent Bio Solutions stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Intelligent Bio sales, a figure that is much harder to manipulate than other Intelligent Bio Solutions multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Intelligent Bio's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Intelligent Bio's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 2.15 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Intelligent Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 3,123 | |
| Geometric Mean | 430.69 | |
| Coefficient Of Variation | 78.89 | |
| Mean Deviation | 2,309 | |
| Median | 4,971 | |
| Standard Deviation | 2,464 | |
| Sample Variance | 6.1M | |
| Range | 5K | |
| R-Value | (0.84) | |
| Mean Square Error | 1.9M | |
| R-Squared | 0.71 | |
| Significance | 0.000041 | |
| Slope | (436.40) | |
| Total Sum of Squares | 91.1M |
Intelligent Price To Sales Ratio History
About Intelligent Bio Financial Statements
Intelligent Bio shareholders use historical fundamental indicators, such as Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Intelligent Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Intelligent Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Intelligent Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 1.08 | 1.02 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.